Physician profile
Christina E Rigas
NPI 1679738694
$24,690.96
in general payments reported to CMS, 2019-2025
44 companies · $15K in 2025
The $15K reported for 2025 was more than what 94% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,834 · 2020: $756 · 2021: $740 · 2022: $2,411 · 2023: $2,396 · 2024: $653 · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $9,184 · Food and Beverage: $6,697 · Travel and Lodging: $1,295 · Education: $625 · Consulting Fee: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $9,184.00 |
| Food and Beverage | $6,696.66 |
| Travel and Lodging | $1,294.77 |
| Education | $624.90 |
| Consulting Fee | $150.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $11,993.96 | 2019-2025 | |
| Glaxosmithkline, LLC. | $2,215.06 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Astrazeneca Pharmaceuticals LP | $1,871.27 | 2019-2025 | Fasenra, Tezspire, Breztri |
| Olympus Corporation of The Americas | $950.38 | 2019 | |
| Harmony Biosciences LLC | $929.74 | 2020-2025 | Wakix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $819.41 | 2019-2025 | Ofev, Jascayd, Spiriva Respimat |
| Actelion Pharmaceuticals US, INC. | $751.48 | 2019-2025 | Uptravi, Opsumit, Opsynvi |
| Mylan Specialty L.P. | $656.62 | 2019-2023 | Yupelri |
| Regeneron Healthcare Solutions, INC. | $478.26 | 2019-2025 | Dupixent |
| Genzyme Corporation | $475.00 | 2019-2025 | |
| Amgen INC. | $355.73 | 2022-2025 | Tezspire |
| Insmed, INC. | $310.79 | 2019-2025 | Arikayce, Brinsupri |
| United Therapeutics Corporation | $281.12 | 2019-2025 | Tyvaso, Tyvaso, Remodulin |
| Mallinckrodt Hospital Products INC. | $189.96 | 2023-2025 | Acthar |
| Novartis Pharmaceuticals Corporation | $189.88 | 2019-2023 |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $187.13 | 2019-2023 | Xolair |
| Merck Sharp & Dohme LLC | $178.52 | 2019-2025 | Winrevair, Verquvo, Belsomra |
| Bayer Healthcare Pharmaceuticals INC. | $175.04 | 2019-2025 | |
| Teva Pharmaceuticals USA, INC. | $174.11 | 2019-2023 | |
| Electromed, INC. | $156.49 | 2019-2025 | Smartvest |
| Takeda Pharmaceuticals U.S.A., INC. | $113.33 | 2023-2025 | Glassia |
| Baxter Healthcare | $108.49 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Inogen, INC. | $104.39 | 2022-2025 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Verona Pharma, INC. | $102.99 | 2025 | Ohtuvayre |
| Axsome Therapeutics, INC. | $96.67 | 2025 | Sunosi |
| Idorsia Pharmaceuticals US INC | $86.95 | 2022-2025 | Quviviq, Quviviq |
| Vapotherm INC | $77.89 | 2022 | |
| Grifols USA, LLC | $76.15 | 2022-2025 | Prolastin-C Liquid |
| Covis Pharma Gmbh | $72.95 | 2022 | |
| Janssen Pharmaceuticals, INC | $71.32 | 2021-2023 | Xarelto |
| Amarin Pharma, INC. | $65.98 | 2021 | |
| Philips North America LLC | $65.71 | 2023-2025 | Image Management Subscription, (Ae4) Secretion Management |
| Sunovion Pharmaceuticals INC. | $60.66 | 2019-2020 | |
| Eisai INC. | $44.35 | 2020-2022 | |
| Itamar Medical INC | $28.35 | 2025 | Watchpatone |
| Azurity Pharmaceuticals, INC. | $25.37 | 2025 | Horizant |
| Nabriva Therapeutics, Plc | $24.11 | 2020 | |
| Pulmonx Corporation | $21.48 | 2025 | Zephyr Endobronchial Valve, Zephyr Delivery Catheter, Chartis Catheter |
| Inspire Medical Systems, INC. | $21.26 | 2025 | Inspire |
| Lilly USA, LLC | $18.50 | 2025 | Zepbound |
| Viatris Specialty LLC | $18.45 | 2025 | Yupelri |
| Esperion Therapeutics, INC. | $17.99 | 2023 | Nexletol |
| Advanced Respiratory, INC | $15.19 | 2019 | |
| Circassia INC. | $12.48 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christina Rigas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.